Kenneth Kovan
Founder chez BIOVAXYS TECHNOLOGY CORP.
Fortune : 411 760 $ au 31/03/2024
Relations actives
| Nom | Sexe | Age | Sociétés liées | Collaboration |
|---|---|---|---|---|
| James Passin | M | 52 |
BioVaxys LLC
 BioVaxys LLC BiotechnologyHealth Technology BioVaxys LLC is a clinical stage biotechnology company, which engages in the development of immunotherapeutic vaccines for antiviral and individualized cancer therapy. It focuses on multihaptenized autologous vaccine that will initially be developed and marketed for melanoma and ovarian cancer. The company was founded by James Passin, Kenneth Kovan and David Berd and is headquartered in New York, NY. | 8 ans |
| David Berd | M | 79 |
BioVaxys LLC
BioVaxys LLC BiotechnologyHealth Technology BioVaxys LLC is a clinical stage biotechnology company, which engages in the development of immunotherapeutic vaccines for antiviral and individualized cancer therapy. It focuses on multihaptenized autologous vaccine that will initially be developed and marketed for melanoma and ovarian cancer. The company was founded by James Passin, Kenneth Kovan and David Berd and is headquartered in New York, NY. | 4 ans |
| Elisabeth Lang | M | - |
Chaperone Technologies, Inc.
 Chaperone Technologies, Inc. Medical SpecialtiesHealth Technology Chaperone Technologies, Inc. develops novel products for infectious diseases. The firm develops and produces peptide-based antimicrobial products to treat infectious diseases. The company was founded by Michael and Elisabeth Lang in March 2014 and is headquartered in Bogart, GA. | - |
| Michael Lang | M | - |
Chaperone Technologies, Inc.
Chaperone Technologies, Inc. Medical SpecialtiesHealth Technology Chaperone Technologies, Inc. develops novel products for infectious diseases. The firm develops and produces peptide-based antimicrobial products to treat infectious diseases. The company was founded by Michael and Elisabeth Lang in March 2014 and is headquartered in Bogart, GA. | 10 ans |
| Craig Loverock | M | 53 | 2 ans | |
| Lachlan McLeod | M | 37 | 4 ans | |
| David Wang | M | - |
BioVaxys LLC
BioVaxys LLC BiotechnologyHealth Technology BioVaxys LLC is a clinical stage biotechnology company, which engages in the development of immunotherapeutic vaccines for antiviral and individualized cancer therapy. It focuses on multihaptenized autologous vaccine that will initially be developed and marketed for melanoma and ovarian cancer. The company was founded by James Passin, Kenneth Kovan and David Berd and is headquartered in New York, NY. | - |
| Stephen Barnes | M | 53 |
Chaperone Technologies, Inc.
Chaperone Technologies, Inc. Medical SpecialtiesHealth Technology Chaperone Technologies, Inc. develops novel products for infectious diseases. The firm develops and produces peptide-based antimicrobial products to treat infectious diseases. The company was founded by Michael and Elisabeth Lang in March 2014 and is headquartered in Bogart, GA. | - |
| Anthony Dutton | M | 66 | 2 ans | |
| Clinton H. Brown | M | - |
Chaperone Technologies, Inc.
Chaperone Technologies, Inc. Medical SpecialtiesHealth Technology Chaperone Technologies, Inc. develops novel products for infectious diseases. The firm develops and produces peptide-based antimicrobial products to treat infectious diseases. The company was founded by Michael and Elisabeth Lang in March 2014 and is headquartered in Bogart, GA. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Statistiques
| Pays | Relations | % du total |
|---|---|---|
| Etats-Unis | 7 | 70,00% |
| Canada | 6 | 60,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Kenneth Kovan
- Réseau Personnel
